Numan secures £10m Series A funding led by Novator to scale operations and technology.
The online health clinic secured backing from Novator alongside Anthemis Exponential, Vostok New Ventures, and Colle Capital.
Numan is a digital health provider offering personalised clinical guidance, diagnostics, and preventative care programmes. The platform focuses on areas including obesity management and men's health.
Digital health clinic Numan has raised £10m in a Series A funding round led by Novator. Participation also came from Anthemis Exponential, Vostok New Ventures, and Colle Capital. The capital will be directed towards technology investment, team expansion, and operational growth.
Founded in 2019, the London-based company operates an online platform providing men with remote access to clinicians, diagnostics, and personalised treatment programmes. The fresh injection of funds follows a period of heightened demand driven by recent health trends and wider public focus on preventive care.
From the founder
"We are building a new kind of healthcare company that gives men simple and accessible solutions for their health and wellbeing problems,"
Sokratis Papafloratos
CEO at Numan
Investor perspective
"We were impressed with Numan’s capital-efficient execution so far and are excited about the future direction of the company. Health is one of the largest economic transformation opportunities still addressable at a global scale, and we’re delighted to be part of Numan’s journey."
Birgir Már Ragnarsson
Board Member, Novator
Use of funds
- 01Build out infrastructure
- 02Scale operations
- 03Grow the team
Investors
Categories
About the company
Numan
Numan operates a digital health platform providing integrated preventative care and diagnostics.